Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

333 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
TP53 deletion is not an adverse feature in multiple myeloma treated with total therapy 3.
Shaughnessy JD, Zhou Y, Haessler J, van Rhee F, Anaissie E, Nair B, Waheed S, Alsayed Y, Epstein J, Crowley J, Barlogie B. Shaughnessy JD, et al. Among authors: anaissie e. Br J Haematol. 2009 Nov;147(3):347-51. doi: 10.1111/j.1365-2141.2009.07864.x. Epub 2009 Aug 21. Br J Haematol. 2009. PMID: 19702643 Free PMC article.
Thalidomide in the management of multiple myeloma.
Barlogie B, Tricot G, Anaissie E. Barlogie B, et al. Among authors: anaissie e. Semin Oncol. 2001 Dec;28(6):577-82. doi: 10.1016/s0093-7754(01)90027-2. Semin Oncol. 2001. PMID: 11740812 Review.
Suppression of abnormal karyotype predicts superior survival in multiple myeloma.
Arzoumanian V, Hoering A, Sawyer J, van Rhee F, Bailey C, Gurley J, Shaughnessy JD Jr, Anaissie E, Crowley J, Barlogie B. Arzoumanian V, et al. Among authors: anaissie e. Leukemia. 2008 Apr;22(4):850-5. doi: 10.1038/sj.leu.2405091. Epub 2008 Jan 17. Leukemia. 2008. PMID: 18200039 Free PMC article.
VTD combination therapy with bortezomib-thalidomide-dexamethasone is highly effective in advanced and refractory multiple myeloma.
Pineda-Roman M, Zangari M, van Rhee F, Anaissie E, Szymonifka J, Hoering A, Petty N, Crowley J, Shaughnessy J, Epstein J, Barlogie B. Pineda-Roman M, et al. Among authors: anaissie e. Leukemia. 2008 Jul;22(7):1419-27. doi: 10.1038/leu.2008.99. Epub 2008 Apr 24. Leukemia. 2008. PMID: 18432260 Free PMC article. Clinical Trial.
Standard and novel imaging methods for multiple myeloma: correlates with prognostic laboratory variables including gene expression profiling data.
Waheed S, Mitchell A, Usmani S, Epstein J, Yaccoby S, Nair B, van Hemert R, Angtuaco E, Brown T, Bartel T, McDonald J, Anaissie E, van Rhee F, Crowley J, Barlogie B. Waheed S, et al. Among authors: anaissie e. Haematologica. 2013 Jan;98(1):71-8. doi: 10.3324/haematol.2012.066555. Epub 2012 Jun 24. Haematologica. 2013. PMID: 22733020 Free PMC article. Clinical Trial.
Thalidomide in total therapy 2 overcomes inferior prognosis of myeloma with low expression of the glucocorticoid receptor gene NR3C1.
Heuck CJ, Szymonifka J, Hansen E, Shaughnessy JD Jr, Usmani SZ, van Rhee F, Anaissie E, Nair B, Waheed S, Alsayed Y, Petty N, Bailey C, Epstein J, Hoering A, Crowley J, Barlogie B. Heuck CJ, et al. Among authors: anaissie e. Clin Cancer Res. 2012 Oct 1;18(19):5499-506. doi: 10.1158/1078-0432.CCR-12-0019. Epub 2012 Aug 1. Clin Cancer Res. 2012. PMID: 22855579 Free PMC article. Clinical Trial.
333 results